Abstract: A method of treating an inflammatory condition involving TNF-? in a mammal by administering to a patient a composition with an effective amount of an isolated alkaline protease in an amount effective to inactive TNF-?. The invention also involves compositions, including pharmaceutical compositions containing an isolated alkaline protease in an amount effective to inactive TNF-? especially those from Aspergillus oryzae and/or serve as a transepithial carrier.
Type:
Application
Filed:
September 12, 2007
Publication date:
March 12, 2009
Applicant:
Kansas University Medical Center Research Institute, Inc.
Inventors:
Michael J. Parmely, Rohit Medhekar, Anthony Collier
Abstract: The present invention provides improved dialysis compositions and methods for dialysis comprising utilizing the disclosed AGE inhibitors, together with methods to reduce dialysis-related complications and disorders.
Type:
Grant
Filed:
April 6, 2000
Date of Patent:
August 20, 2002
Assignee:
Kansas University Medical Center Research Institute
Inc.
Abstract: The present invention provides methods to isolate and purify components required for bone-induction using extracts of Saos-2 cells or proteins released by Saos-2 cells into conditioned tissue culture medium. In addition, the present invention provides a method of augmenting bone growth locally comprising implanting the near osteoprogenitor cells the bone inducing agent isolated in the methods of the present invention, together with a mechanically suitable biodegradable carrier.
Type:
Grant
Filed:
February 13, 1997
Date of Patent:
November 27, 2001
Assignee:
Kansas University Medical Center Research Institute,
Inc.